Literature DB >> 8698617

Primary malignant lymphoma of the brain: demonstration of frequent p16 and p15 gene deletions.

T Kumanishi1, S Zhang, T Ichikawa, S Endo, K Washiyama.   

Abstract

The p16 (MTS-1) gene, a candidate tumor suppressor gene, was examined by means of Southern blot, PCR-SSCP (polymerase chain reaction-single-strand conformation polymorphism) and nucleotide analyses in 5 cases of primary malignant lymphoma of the brain. By Southern blot analysis, the p16 gene was found to be deleted in at least 4 cases, homozygously (3 cases) or hemizygously (1 case). The p15 (MTS-2) gene, another candidate tumor suppressor gene located in the vicinity of the p16 gene, to which it shows structural and functional similarity, was also found to be deleted in 4 cases. Our frequent detection (80%) of p16 and p15 gene deletions might suggest that these deletions are closely related to carcinogenesis in primary malignant lymphoma of the brain. SSCP and nucleotide analyses revealed no mutations of the p16 gene in any of the cases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698617      PMCID: PMC5921166          DOI: 10.1111/j.1349-7006.1996.tb00279.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  31 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma.

Authors:  P R Koduru; M Zariwala; M Soni; J Z Gong; Y Xiong; J D Broome
Journal:  Blood       Date:  1995-10-15       Impact factor: 22.113

3.  Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.

Authors:  T Hayakawa; K Takakura; H Abe; T Yoshimoto; R Tanaka; K Sugita; H Kikuchi; T Uozumi; T Hori; H Fukui
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Primary malignant lymphoma of the brain: demonstration of the p53 gene mutations by PCR-SSCP analysis and immunohistochemistry.

Authors:  H Koga; S Zhang; T Ichikawa; K Washiyama; T Kuroiwa; R Tanaka; T Kumanishi
Journal:  Noshuyo Byori       Date:  1994

5.  Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma -- a proposal of a new type.

Authors:  T Suchi; K Tajima; K Nanba; H Wakasa; A Mikata; M Kikuchi; S Mori; S Watanabe; N Mohri; M Shamoto; K Harigaya; T Itagaki; M Matsuda; Y Kirino; K Takagi; S Fukunaga
Journal:  Acta Pathol Jpn       Date:  1979-09

6.  Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma.

Authors:  T Mori; K Miura; T Aoki; T Nishihira; S Mori; Y Nakamura
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

7.  CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

Authors:  E E Schmidt; K Ichimura; G Reifenberger; V P Collins
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

8.  Mutational analysis of the CDKN2 (MTS1/p16ink4A) gene in primary B-cell lymphomas.

Authors:  T Uchida; T Watanabe; T Kinoshita; T Murate; H Saito; T Hotta
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113

9.  p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.

Authors:  G J Hannon; D Beach
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

10.  Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas.

Authors:  A F Gombart; R Morosetti; C W Miller; J W Said; H P Koeffler
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

View more
  5 in total

1.  Chromosomal imbalances in primary lymphomas of the central nervous system.

Authors:  C H Rickert; B Dockhorn-Dworniczak; R Simon; W Paulus
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  Establishment of two glioma cell lines from two surgical specimens obtained at different times from the same individual.

Authors:  K Onda; S Nagai; R Tanaka; K Morii; J I Yoshimura; I Tsumanuma; T Kumanishi
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

Review 3.  Classification, pathogenesis and molecular pathology of primary CNS lymphomas.

Authors:  W Paulus
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

4.  A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations.

Authors:  S Zhang; S Endo; H Koga; T Ichikawa; X Feng; K Onda; K Washiyama; T Kumanishi
Journal:  Jpn J Cancer Res       Date:  1996-09

5.  Primary malignant lymphoma of the brain: mutation pattern of rearranged immunoglobulin heavy chain gene.

Authors:  Sumio Endo; Shu-Jing Zhang; Takafumi Saito; Mitsuo Kouno; Toshihiko Kuroiwa; Kazuo Washiyama; Toshiro Kumanishi
Journal:  Jpn J Cancer Res       Date:  2002-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.